Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Intravenous immunoglobulin therapy].

Luc Mouthon1

  • 1Service de médecine interne, hôpital Cochin, 75679 Paris Cedex 14. luc.mouthon@cch.aphp.fr

La Revue Du Praticien
|August 16, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Moderators of Loneliness Trajectories in People with Systemic Sclerosis During the COVID-19 Pandemic: A SPIN COVID-19 Cohort Longitudinal Study.

International journal of behavioral medicine·2024
Same author

Authors reply: Clinical presentation, course, and prognosis of patients with mixed connective tissue disease.

Journal of internal medicine·2024
Same author

Pulmonary arterial hypertension associated with connective tissue diseases (CTD-PAH): Recent and advanced data.

Autoimmunity reviews·2023
Same author

Interstitial lung disease phenotype in mixed, differentiated, or overlapping, connective tissue diseases: Comment on the article by Boleto et al.

Seminars in arthritis and rheumatism·2023
Same author

Clinical presentation, course, and prognosis of patients with mixed connective tissue disease: A multicenter retrospective cohort.

Journal of internal medicine·2023
Same author

Takotsubo syndrome occurring in systemic diseases: A French multicenter retrospective case-control study and literature review.

Autoimmunity reviews·2023
Same journal

[Prolonged fever].

La Revue du praticien·2026
Same journal

[Lower gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[A history of child abuse intervention in the West].

La Revue du praticien·2026
Same journal

[Agranulocytose médicamenteuse].

La Revue du praticien·2026
Same journal

[Patient education in heart failure].

La Revue du praticien·2026
See all related articles

Intravenous immunoglobulins (IVIg) offer therapeutic benefits for immune deficiencies and autoimmune diseases. Further research into their mechanisms could reveal new treatment indications.

Area of Science:

  • Immunology
  • Pharmacology
  • Hematology

Context:

  • Intravenous immunoglobulins (IVIg) are derived from pooled human IgG from healthy donors.
  • IVIg serves dual roles: low-dose substitution for immunodeficiencies and high-dose immunomodulation for autoimmune/inflammatory conditions.

Purpose:

  • To review the therapeutic applications, safety profile, and mechanisms of action of IVIg.
  • To explore the potential for new indications based on ongoing research.

Summary:

  • IVIg is utilized in treating primary/secondary immune deficiencies and various autoimmune/inflammatory diseases, notably in hematologic and neurologic contexts.
  • Generally well-tolerated, IVIg carries only a theoretical risk of infectious agent transmission.
  • The complex mechanisms of IVIg action are under investigation.

Related Experiment Videos

Impact:

  • Understanding IVIg's multifaceted actions can guide the development of novel therapeutic strategies.
  • This review highlights the broad clinical utility and future potential of IVIg therapy.